News
    Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
    IRVINE, Calif., Oct. 16, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD Micro, on Tuesday, October 29th in Los Angeles.

    16 October 2024

    read more...
    OCXOncocyteDiagnostic TechnologyHEALTHCAREHealth TechNASDAQStock Indexpress releaseNews ReleasebiotechStock MarketPRISM DigitalMediaPRISM MarketViewPRISM MediaWire
    News
    Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
    KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates

    15 October 2024

    read more...
    KLTOKlotho NeurosciencesHEALTHCARENASDAQpress releaseNews ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWirebiotechStock Market
    News
    Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
    PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman,...

    9 October 2024

    read more...
    LIPOLipella PharmaceuticalsNASDAQpharmaceuticalBiopharmaceuticalHEALTHCAREpress releaseNews ReleasePRISM DigitalMediaPRISM MarketViewbiotechStock MarketPRISM MediaWire
    News
    Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to  Atezolizumab in Phase 2 Clinical Trial
    · Results published in peer-reviewed journal, Clinical Cancer Research

    8 October 2024

    read more...
    OCXDiagnostic TechnologyOncocyteHEALTHCAREBiopharmaceuticalNASDAQpress releaseNews ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWireBiotechstock market
    News
    IONQ Achieves Important Achievement Progressing Ion-Ion Entanglement
    New York, October 04, 2024 - PRISM MediaWire - IonQ, (NYSE: IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglemen...

    4 October 2024

    read more...
    News
    Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
    Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories

    2 October 2024

    read more...
    OCXOncocyteNASDAQDiagnostic TechnologyHEALTHCAREBiopharmaceuticalNews Releasepress releasePRISM DigitalMediaPRISM MarketViewbiotechPRISM MediaWirestock market
    News
    Digital Utilities Ventures Reports Strong Fiscal Year 2024 - Advancing Leadership in Green Technologies
    MANKATO, MN, September 23, 2024 - PRISM MediaWire - Digital Utilities Ventures, Inc. (OTC: DUTV), a leader in sustainable energy and environmental technologies, recently announced its financial results and corporate progress for the fiscal year ended May 31, 2024. The co...

    23 September 2024

    read more...
    DUTVDigital Utilities VentureEasy Energy SystemsEasy Energy FinanceBiofertilizersenvironmentalsustainable energyOTCOTC MarketsStock MarketbiotechTechnologyNews ReleasePress ReleasePRISM DigitalMediaPRISM MarketViewPRISM MediaWire
    News
    ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
    Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity

    17 September 2024

    read more...
    WENAKLTOpharmaceuticalHEALTHCAREKlotho NeurosciencesNASDAQbiotechpress releaseNews ReleasePRISM DigitalMediastock marketPRISM MarketViewPRISM MediaWire
    News
    PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
    PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

    13 September 2024

    read more...
    News
    Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
    Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI

    11 September 2024

    read more...
    HALBHalberd CorporationBiotechnologyBiopharmaceuticalHEALTHCAREWatchDawgOTCOTC MarketsNews ReleasePRISM DigitalMediaPRISM MarketViewbiotechstock marketPRISM MediaWirePress Release
    1
    2
    3
    4
    5
    6
    7
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.